Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
about
Drug therapy for chronic idiopathic axonal polyneuropathyTreatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patientsUpdates in diabetic peripheral neuropathyBrain changes in diabetes mellitus patients with gastrointestinal symptomsDiabetic neuropathic pain: Physiopathology and treatmentMitochondrial stress and the pathogenesis of diabetic neuropathyNutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetesSchwann cell interactions with axons and microvessels in diabetic neuropathy.Is type 2 diabetes related to leukoaraiosis? an updated review.Mechanosensitivity during lower extremity neurodynamic testing is diminished in individuals with Type 2 Diabetes Mellitus and peripheral neuropathy: a cross sectional studyResting-state functional MR imaging shed insights into the brain of diabetes.Efficacy, safety, and tolerability of Epalrestat compared to Methylcobalamine in patients with diabetic neuropathy.Cardio-Ankle Vascular Index and Indices of Diabetic Polyneuropathy in Patients with Type 2 Diabetes.High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus LRelationship between modified homeostasis model assessment/correlative serum factors and diabetic retinopathy among type 2 diabetics with insulin therapy in Guangzhou, ChinaMetabolome and proteome changes with aging in Caenorhabditis elegans.New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}Diabetic neuropathy part 1: overview and symmetric phenotypesA preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus.Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.Impact of diabetes and peripheral arterial occlusive disease on the functional microcirculation at the plantar foot.Role of neural NO synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese Zucker rats.Diabetic neuropathy: clinical manifestations and current treatments.Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study.Puerarin prevents high glucose-induced apoptosis of Schwann cells by inhibiting oxidative stress.p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated miceThymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic miceStructural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.Effect of high-fat diet on peripheral neuropathy in C57BL/6 miceErectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.Is the C677T polymorphism in methylenetetrahydrofolate reductase gene or plasma homocysteine a risk factor for diabetic peripheral neuropathy in Chinese individuals?Clinical characteristics of patients with diabetic polyneuropathy: the role of clinical and electromyographic evaluation and the effect of the various types on the quality of life.Haemodynamics in microvascular complications in type 1 diabetes.Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathyOxidative stress and diabetic neuropathy: a new understanding of an old problemTranscriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes.Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db miceThe effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy.
P2860
Q24247228-2A8D28FA-83F8-4A33-A33E-26BC4B25EA90Q24646981-2E5F4E2A-9A97-47CC-8C1C-E1AA5A43A208Q26751252-F647B448-68C1-4AA9-9372-4BA591EAFE52Q26769999-9C20050F-C051-40F5-B9C7-117E8261802AQ27004604-A847D0B3-F767-45F2-B84E-067743A1ACEEQ28382887-9EF853F8-C426-40A3-B27B-C44687EF47B8Q28385506-57872C1C-E85F-4ADB-A5EB-3D7818F34E89Q30238727-B042A8D6-AD38-4F95-8522-A935E6A44B90Q30910261-C5F938E1-6AB4-418C-B609-5C1AD63FF44CQ30988459-20E32087-DBDF-4718-8BB9-DB201607CBAFQ31117440-61308203-0A56-4CA5-97A5-66B87EA5F550Q33574361-D5E67490-0429-4E51-89FE-B598C1ED11A7Q33717590-C7EA05F3-15F3-46EC-8DB2-F245E624ED67Q33781251-36E0E82D-851D-4481-8FF6-65A81AB35F79Q33794986-91C82965-48F5-45BC-AADD-FBC90B4E5778Q33807271-F29B795F-9AED-4C73-A6DC-B583027A72C6Q33874485-E1DAAD95-2E4C-48D3-A19D-F3645ED9C949Q33878023-E38409E3-8F6D-4E90-930C-B8075C21D77AQ33979020-24F4BEBF-6552-4680-8548-8A5D07B9DB6EQ34104944-8289059D-76D6-4D2C-9414-9C3B7FDC5374Q34238965-9D85F7ED-23EB-4D74-9B64-43844356DF03Q34249452-1E4FB62A-1B4C-4167-8945-E15FA142D174Q34275990-C1269812-1E49-4A01-9452-B43B49201D46Q34301089-72C7B1A1-7385-44E5-828A-343794734031Q34351867-8D91E938-28B1-44A8-A55C-3E50DD552706Q34358231-894A7BC5-5035-45DA-827A-4E5F4BE6DB59Q34376157-41B54428-2680-442F-B8B0-F804C6B5DB90Q34393516-36E41BCF-7DDF-4AF1-9DCE-B014CB6A4685Q34420840-B7B927B3-34DF-4946-8362-DD3F8FA7AF7DQ34487599-4FEE8E7F-FA3D-4E78-97B8-EDBF3003CACCQ34498189-B487C3F6-6F48-48A5-A3BD-403EE9205BD0Q34591301-81652AA0-856D-424D-B247-73DED96FBF5DQ34720302-D288401C-6B82-4C0E-8243-61113C449349Q34769758-536B75B9-3A36-4A65-A80E-54FDDA2C3C98Q34804249-E2C0DC9A-748C-4EAF-AB6C-B538C421E57BQ34836985-9CDFBBFF-92CA-4FD8-9141-A64C24FF6744Q34838448-11E875B4-71AA-467C-B1AB-1B24573BD67AQ35063229-50CCF062-65EB-4A6A-AC39-F2835BEF2A56Q35083219-FE3D741B-47C0-4CBF-A19B-9492154C2C4CQ35153023-9853FC63-646C-41E9-84EE-29A0C8707AA7
P2860
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@ast
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@en
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@nl
type
label
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@ast
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@en
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@nl
prefLabel
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@ast
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@en
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
@nl
P2093
P356
P1433
P1476
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
@en
P2093
P2888
P304
P356
10.1007/S001250100001
P577
2001-11-01T00:00:00Z
P5875
P6179
1002654976